Investigational Drug Details
Drug ID: | D571 |
Drug Name: | GW7647 |
Synonyms: | -- |
Type: | Miscellany |
DrugBank ID: | -- |
DrugBank Description: | -- |
PubChem ID: | -- |
CasNo: | -- |
Repositioning for NAFLD: | No |
SMILES: | -- |
InChiKey: | -- |
Molecular Weight: | -- |
DrugBank Targets: | -- |
DrugBank MoA: | -- |
DrugBank Pharmacology: | -- |
DrugBank Indication: | -- |
Targets: | PPARα agonist |
Therapeutic Category: | Anti-diabetic drugs |
Clinical Trial Progress: | -- |
Latest Progress: | Under investigation |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
---|
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Article ID | PMID | Source | Title | |
---|---|---|---|---|
A05645 | 33177546 | Sci Rep | PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat. | Details |
A50740 | 35282837 | Lipids Health Dis | Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα. | Details |